Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

ClinicalTrials.gov ID: NCT06113471

Public ClinicalTrials.gov record NCT06113471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 12:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Study identification

NCT ID
NCT06113471
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
450 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 27, 2023 (Actual)
Primary completion
Mar 17, 2026 (Actual)
Completion
Mar 16, 2027 (Estimated)
Last update posted
Mar 31, 2026

2023 – 2027

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
28
Facility City State ZIP Site status
University of Alabama At Birmingham Hospital-Whitaker Clinic Birmingham Alabama 35294-0007 —
C2 Research Center, Llc Montgomery Alabama 36117 —
First Oc Dermatology Research Inc Fountain Valley California 92708-3701 —
Center For Dermatology Clinical Research, Inc Fremont California 94538 —
Marvel Clinical Research Llc Huntington Beach California 92647 —
Vitiligo & Pigmentation Institute of Southern California Los Angeles California 90036-5609 —
Dermatology Research Associates Los Angeles California 90045 —
Clinical Trials Research Institute Thousand Oaks California 91320 —
Skin Care Research, Llc Boca Raton Florida 33486 —
Total Vein and Skin Llc Boynton Beach Florida 33437 —
Driven Research Llc Coral Gables Florida 33134 —
Florida Academic Centers Research and Education Llc Coral Gables Florida 33134 —
Pediatric Skin Research Llc Coral Gables Florida 33146 —
Metabolic Research Institute Inc West Palm Beach Florida 33401 —
Dermatology and Surgery Specialists of North Atlanta Marietta Georgia 30068 —
Advanced Medical Research Pc Sandy Springs Georgia 30328 —
Dundee Dermatology West Dundee Illinois 60118 —
Indiana University School of Medicine Iusm Indianapolis Indianapolis Indiana 46202-3082 —
Delricht Research Baton Rouge Louisiana 70809 —
Callender Dermatology and Cosmetic Center Glenn Dale Maryland 20769 —
Aesthetic and Dermatology Center Rockville Maryland 20850 —
Henry Ford Health System Detroit Michigan 48202 —
Allcutis Research, Llc Portsmouth New Hampshire 03801 —
Weill Cornell Medical College New York New York 10065 —
Remington-Davis Clinical Research Columbus Ohio 43215 —
Oregon Medical Research Center, Pc Portland Oregon 97223 —
Dermatology Treatment and Research Center Dallas Texas 75230 —
Heights Dermatology and Aesthetic Center Houston Texas 77008 —
University of Texas, Md Anderson Cancer Houston Texas 77030 —
Innovative Dermatology: Legacy Medical Village Plano Texas 75024 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229 —
Premier Clinical Research Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06113471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06113471 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →